Squarepoint
TAK icon

Squarepoint’s Takeda Pharmaceutical TAK Stock Holding History

Squarepoint’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-54,391
Closed -$1.01M – 4964
2026
Q1 		$1.01M Buy
+54,391
New +$955K ﹤0.01% 2776
2025
Q4 		– Sell
-203,810
Closed -$2.98M – 4880
2025
Q3 		$2.98M Buy
203,810
+159,705
+362% +$2.37M ﹤0.01% 1787
2025
Q2 		$682K Sell
44,105
-19,528
-31% -$289K ﹤0.01% 3003
2025
Q1 		$946K Buy
+63,633
New +$892K ﹤0.01% 2725
2024
Q4 		– Sell
-64,674
Closed -$920K – 5486
2024
Q3 		$920K Buy
+64,674
New +$917K ﹤0.01% 2668
2024
Q2 		– Sell
-66,760
Closed -$927K – 4638
2024
Q1 		$927K Buy
66,760
+41,656
+166% +$606K ﹤0.01% 2653
2023
Q4 		$358K Buy
+25,104
New +$356K ﹤0.01% 3243
2023
Q2 		– Sell
-48,110
Closed -$793K – 4004
2023
Q1 		$793K Buy
+48,110
New +$766K ﹤0.01% 2037
2022
Q1 		– Sell
-24,763
Closed -$338K – 3498
2021
Q4 		$338K Buy
+24,763
New +$347K ﹤0.01% 2381
2021
Q3 		– Sell
-13,276
Closed -$223K – 3414
2021
Q2 		$223K Sell
13,276
-4,753
-26% -$80.9K ﹤0.01% 2742
2021
Q1 		$329K Buy
+18,029
New +$324K ﹤0.01% 2334
2020
Q4 		– Sell
-37,434
Closed -$668K – 3253
2020
Q3 		$668K Buy
+37,434
New +$682K 0.01% 1219
2020
Q1 		– Sell
-13,148
Closed -$259K – 2492
2019
Q4 		$259K Buy
+13,148
New +$252K ﹤0.01% 2109
2019
Q2 		– Sell
-11,281
Closed -$230K – 2661
2019
Q1 		$230K Buy
+11,281
New +$227K ﹤0.01% 1888

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Squarepoint's TAK Position: Q2 2026 in Review

Squarepoint sold out of Takeda Pharmaceutical (TAK) in Q2 2026, closing a stake of 54,391 shares — an estimated $1.01M sold.

Squarepoint first reported a position in TAK in Q1 2019 and held it in 14 quarters. The position peaked at $2.98M in Q3 2025. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Squarepoint reported no remaining Takeda Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Squarepoint sold 54,391 Takeda Pharmaceutical shares in Q2 2026, an estimated $1.01M.
  • Squarepoint first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 14 quarters.
  • Squarepoint's Takeda Pharmaceutical position peaked at $2.98M in Q3 2025.
  • 378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.